Delivery Vehicles
Cationic Porphyrins For Antisense Oligodeoxynucleotide Delivery
Published in Gene Therapy Weekly, February 8th, 1999
L. Benimetskaya and colleagues from Columbia University, New York, explored the use of cationic porphyrins as novel delivery vehicles for ODNs ("Cationic Porphyrins: Novel Delivery Vehicles for Antisense Oligodeoxynucleotides," Nucleic Acids Research, December 1, 1998;26(23):5310-5317).
"Cationic porphyrins form stable complexes with oligo-deoxynucleotides," wrote Benimetskaya et al. "To evaluate delivery, we used a 20mer phosphorothioate oligomer (Isis 3521) targeted to the 3'-untranslated region of the PKC-alpha mRNA, and complexed it...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1999-02-08)
More Articles from Gene Therapy Weekly
- Vector Evaluation
A Semipermissive Host Model Tolerated an Adenoviral Vector - Antisense Therapy (HIV)
Oligonucleotide Analogues Inhibit Reverse Transcription - Cancer Gene Therapy
Cell-Specific Gene Therapy against Thyroid Cancer Explored - Cancer Immunotherapy
TGF-(beta) Antisense Therapy Prolongs Survival - Immunogene Therapy
Receptor-Mediated Gene Delivery Uses Fab Fragments - Oligonucleotide Therapy
Gene Therapy Through Skin May Use Oligonucleotides - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
